Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) FCF Margin (2016 - 2026)

Orthofix Medical has reported FCF Margin over the past 17 years, most recently at 15.19% for Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin fell 136.0% year-over-year to 15.19%, compared with a TTM value of 0.56% through Mar 2026, up 9.0%, and an annual FY2025 reading of 0.16%, up 106.0% over the prior year.
  • FCF Margin came in at 15.19% for Q1 2026, down from 7.65% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 9.27% in Q4 2024 to a low of 28.04% in Q1 2023.
  • Median FCF Margin over the past 5 years was 10.25% (2022), compared with a mean of 7.36%.
  • The sharpest move saw FCF Margin crashed -1396bps in 2023, then skyrocketed 2494bps in 2024.
  • Over 5 years, FCF Margin stood at 6.95% in 2022, then plummeted by -125bps to 15.67% in 2023, then surged by 159bps to 9.27% in 2024, then fell by -17bps to 7.65% in 2025, then plummeted by -299bps to 15.19% in 2026.
  • Per Business Quant, the three most recent readings for OFIX's FCF Margin are 15.19% (Q1 2026), 7.65% (Q4 2025), and 1.29% (Q3 2025).